本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mirum Pharmaceuticals, Inc.

95.81
-0.4300-0.45%
成交量:37.36萬
成交額:3,588.10萬
市值:57.81億
市盈率:-203.85
高:97.05
開:95.87
低:93.88
收:96.24
52周最高:109.28
52周最低:36.88
股本:6,034.16萬
流通股本:3,998.57萬
量比:0.32
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-0.4700
每股收益(LYR):-0.4700
淨資產收益率:-8.65%
總資產收益率:-1.83%
市淨率:18.37
市盈率(LYR):-203.85

資料載入中...

2025/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report